HORAN Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.31M Buy
21,016
+11,525
+121% +$728K 0.13% 94
2026
Q2
$547K Sell
9,491
-8,965
-49% -$515K 0.07% 139
2026
Q1
$1.03M Buy
18,456
+9,229
+100% +$538K 0.1% 95
2025
Q4
$498K Sell
9,227
-844
-8% -$40.6K 0.08% 121
2025
Q3
$454K Buy
+10,071
New +$470K 0.07% 137

Other funds holding BMY

HORAN Wealth's BMY Position: Q3 2026 in Review

HORAN Wealth increased its Bristol-Myers Squibb (BMY) stake by 121% in Q3 2026, buying an estimated $728K and bringing the position to 21,016 shares worth $1.31M. The position accounts for 0.13% of the portfolio, ranked #94.

HORAN Wealth first reported a position in BMY in Q3 2025 and has held it in 5 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • HORAN Wealth held 21,016 shares of Bristol-Myers Squibb worth $1.31M as of Q3 2026.
  • HORAN Wealth bought 11,525 Bristol-Myers Squibb shares in Q3 2026, an estimated $728K.
  • Bristol-Myers Squibb made up 0.13% of HORAN Wealth's portfolio in Q3 2026, its #94 holding.
  • HORAN Wealth first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 5 quarters since.
  • 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on HORAN Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.